Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This describes the 'Explore Data' table.

This is not a card, but an explore table.

File view driving this table: https://www.synapse.org/#!Synapse:syn9630847/tables/

The following is a brief description of the relevant columns in the table below (by column header):

column portal name: name as it should appear in data portal

current synapse file view column: corresponding name (e.g., for SQL query) in Synapse table vieweventual synapse file view column: name (e.g., for SQL query) in Synapse table view that we will eventually migrate todifference between current and eventual columns: as we migrate to GDC, we will put new annotation keys in "eventual" column names. for now, use "current."

facet: true if column_name should be faceted in data portal.

card location: primary (i.e., top) or secondary (i.e., bottom) key/annotation


desired for CSBC/PS-ON: should this column be included in the CSBC data portal

...

The following have been added to the synapse table, but are blank. They need to be filled in:

column portal namecurrent synapse file view columneventual synapse file view columnfacetcard locationconceptexampleGDC equivalentfaceted on GDCfacet on CSBCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portal
Grant Type

yesNA
U54 or U01








Grant

yesNA










Program

yesNA
CSBC or PSON








Speciesspeciesspeciesyessecondary

none
yes





Scientific ThemeNAthemeyessecondary(or possibly pill directly beneath file name)
tumor-heterogeneitynone
yes





Data Categoryassaydata_categoryyessecondaryBroad categorization of the contents of the data file.
  • Transcriptome Profiling
data_categoryyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Data TypeNAdata_typeno?NASpecific content type of the data file.
  • Exon Expression Quantification
  • Gene Expression Quantification
  • Isoform Expression Quantification
  • Splice Junction Quantification
data_typeyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Data FormatfileFormatdata_formatno?NAFormat of the data files.
  • CSV
  • HDF5
  • TSV
  • TXT
  • SRA XML
  • MAGE-TAB
  • SDRF
  • IDF
  • ADF
data_formatyesyes





Experiment Strategyassayexperimental_strategyyessecondaryThe sequencing strategy used to generate the data file.  REMOVE "sequencing" for CSBC.
  • RNA-Seq
  • Total RNA-Seq
experimental_strategyyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

File Name

noprimaryThe name (or part of a name) of a file (of any type).
file_namenono





file_size

noNAThe size of the data file (object) in bytes.
file_sizenono





md5sum

noNAThe 128-bit hash value expressed as a 32 digit hexadecimal number (in lower case) used as a file's digital fingerprint.
md5sumnono





Platform

yesNA

platformyesyes





Disease Type

yessecondaryThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




Site

yessecondaryThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




Ethnicity

noNAAn individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • hispanic or latino
  • not hispanic or latino
  • Unknown
  • not reported
  • not allowed to collect
demographic/ethnicityyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




Gender

noNAText designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Explanatory Comment 1: Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]
  • female
  • male
  • unknown
  • unspecified
  • not reported
demographic/genderyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




Race

noNAAn arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • white
  • american indian or alaska native
  • black or african american
  • asian
  • native hawaiian or other pacific
demographic/raceyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




Tissue

yessecondaryThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Age

yes (can we facet by range–i.e., between age 20 and 30?)NAAge at the time of diagnosis expressed in number of days since birth.
diagnosis/age_at_diagnosisyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Primary Diagnosis

noNAText term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdominal desmoid
  • Abdominal fibromatosis
  • Achromic nevus
  • Acidophil adenocarcinoma
  • Acidophil adenoma
diagnosis/primary_diagnosisnonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Progression

noNAYes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
  • yes
  • no
  • unknown
  • not reported
  • Not Allowed To Collect
diagnosis/progression_or_recurrencenonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Vital Status

noNAThe survival state of the person registered on the protocol.
  • alive
  • dead
  • lost to follow-up
  • unknown
  • not reported
diagnosis/vital_statusyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Sample Type

noNAText term to describe the source of a biospecimen used for a laboratory test.
  • Additional Metastatic
  • Additional - New Primary
  • Blood Derived Cancer - Bone Marrow, Post-treatment
  • Blood Derived Cancer - Peripheral Blood, Post-treatment
  • Blood Derived Normal
  • Bone Marrow Normal
  • Buccal Cell Normal
  • Cell Line Derived Xenograft Tissue
  • Cell Lines
sample/sample_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




Tissue Type

noNAText term that represents a description of the kind of tissue collected with respect to disease status or proximity to tumor tissue.
  • Tumor
  • Normal
  • Abnormal
  • Peritumoral
  • Unknown
sample/tissue_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




...